Literature DB >> 12767054

Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.

Masanori Kanatani1, Toshitsugu Sugimoto, Junichi Kano, Michiko Kanzawa, Kazuo Chihara.   

Abstract

Although high inorganic phosphate (Pi) concentration in culture media directly inhibits generation of new osteoclasts and also inhibits bone resorption by mature osteoclasts, its precise mechanism and the physiological role have not been elucidated. The present study was performed to investigate these issues. Increase in extracellular Pi concentration ([Pi](e)) (2.5-4 mM) concentration dependently inhibited 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] or parathyroid hormone (PTH)-(1-34)-induced osteoclast-like cell formation from unfractionated bone cells in the presence of stromal cells. Increase in [Pi](e) (2.5-4 mM) concentration dependently inhibited 1,25(OH)(2)D(3)-, PTH-(1-34)-, or receptor activator of NF-kappaB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF)-induced osteoclast-like cell formation from hemopoietic blast cells in the absence of stromal cells. Increase in [Pi](e) (2.5-4 mM) dose dependently stimulated the expression of osteoprotegerin (OPG) mRNA and increased the expression of OPG mRNA suppressed by PTH-(1-34) or 1,25(OH)(2)D(3) in unfractionated bone cells, while it did not affect RANKL mRNA. Increase in [Pi](e) (2.5-4 mM) concentration dependently inhibited the bone-resorbing activity of isolated rabbit osteoclasts. Increase in [Pi](e) (4 mM) induced the apoptosis of isolated rabbit osteoclasts while it did not affect the apoptosis of osteoclast precursor cells and mouse macrophage-like cell line C7 cells that can differentiate into osteoclasts in the presence of RANKL and M-CSF. These results indicate that increase in [Pi](e) inhibits osteoclast differentiation both by up-regulating OPG expression and by direct action on osteoclast precursor cells. It is also indicated that increase in [Pi](e) inhibits osteoclastic activity at least in part by the direct induction of apoptosis of osteoclasts. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767054     DOI: 10.1002/jcp.10270

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  23 in total

Review 1.  The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals.

Authors:  Solmaz Khoshniat; Annabelle Bourgine; Marion Julien; Pierre Weiss; Jérôme Guicheux; Laurent Beck
Journal:  Cell Mol Life Sci       Date:  2010-09-17       Impact factor: 9.261

2.  PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria.

Authors:  Michael Föller; Daniela S Kempe; Krishna M Boini; Ganesh Pathare; Balasaheb Siraskar; Paola Capuano; Ioana Alesutan; Mentor Sopjani; Gerti Stange; Nilufar Mohebbi; Madhuri Bhandaru; Teresa F Ackermann; Martin S Judenhofer; Bernd J Pichler; Jürg Biber; Carsten A Wagner; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

3.  Nanoparticulate mineralized collagen glycosaminoglycan materials directly and indirectly inhibit osteoclastogenesis and osteoclast activation.

Authors:  Xiaoyan Ren; Qi Zhou; David Foulad; Marley J Dewey; David Bischoff; Timothy A Miller; Dean T Yamaguchi; Brendan A C Harley; Justine C Lee
Journal:  J Tissue Eng Regen Med       Date:  2019-04-15       Impact factor: 3.963

Review 4.  Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.

Authors:  Miyuki Kuno
Journal:  Pflugers Arch       Date:  2018-03-17       Impact factor: 3.657

5.  Phosphate (Pi)-regulated heterodimerization of the high-affinity sodium-dependent Pi transporters PiT1/Slc20a1 and PiT2/Slc20a2 underlies extracellular Pi sensing independently of Pi uptake.

Authors:  Nina Bon; Greig Couasnay; Annabelle Bourgine; Sophie Sourice; Sarah Beck-Cormier; Jérôme Guicheux; Laurent Beck
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

6.  Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3.

Authors:  Madhuri Bhandaru; Daniela S Kempe; Anand Rotte; Paola Capuano; Ganesh Pathare; Mentor Sopjani; Ioana Alesutan; Leonid Tyan; Dan Yang Huang; Balasaheb Siraskar; Martin S Judenhofer; Gerti Stange; Bernd J Pichler; Jürg Biber; Leticia Quintanilla-Martinez; Carsten A Wagner; David Pearce; Michael Föller; Florian Lang
Journal:  Kidney Int       Date:  2011-03-30       Impact factor: 10.612

Review 7.  Advances in renal bone disease: osteoporosis and chronic kidney disease.

Authors:  Sara Barnato; Stuart M Sprague
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 8.  Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?

Authors:  W Jeffcoate
Journal:  Diabetologia       Date:  2004-08-21       Impact factor: 10.122

9.  An integrated understanding of the physiological response to elevated extracellular phosphate.

Authors:  Corinne E Camalier; Ming Yi; Li-Rong Yu; Brian L Hood; Kelly A Conrads; Young Jae Lee; Yiming Lin; Laura M Garneys; Gary F Bouloux; Matthew R Young; Timothy D Veenstra; Robert M Stephens; Nancy H Colburn; Thomas P Conrads; George R Beck
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

10.  Bone biochemical markers for assessment of bone responses to differentiated phosphorus supply in growing-finishing pigs.

Authors:  Kristina U Sørensen; Marlena C Kruger; Jens Hansen-Møller; Hanne D Poulsen
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.